LAVAL, QC,
As part of the conditions of the Standby Purchase agreement signed at the time of the
"To date, the Fund has been a very supportive shareholder which shares our vision of making LRI one of the world-leading providers of non-clinical services to the health care market. The recent participation of the Fund in the Rights Offering has been a key contributing factor of its success, and we look forward to working with
About LAB Research Inc.:
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in
LAB Research's shares trade on The
This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.
%SEDAR: 00023798EF
For further information: Luc Mainville, Chief Executive Officer, (450) 973-2240 (ext. 1206), [email protected], www.labresearch.com; Frédéric Dumais, Partner, Jasmin-Dumais Financial Communications, (514) 862-1251, [email protected]
Share this article